The human SIN3B corepressor forms a nucleolar complex with leukemia-associated ETO homologues

BMC Molecular Biology

Volumn 9, Issue 1, 2008, Pages

  Dhanda, Rakesh Singh ^a   Lindberg, Sofia Rondin ^a   Olsson, Inge ^a  

^a Department of Hematology ^*  (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MYELOID TRANSFORMING GENE 16; MYELOID TRANSFORMING GENE RELATED PROTEIN 1; PROTEIN CBFA2T1; SIN3B COREPRESSOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; CBFA2T2 MYELOID TRANSFORMING GENE RELATED PROTEIN; CBFA2T2 MYELOID-TRANSFORMING GENE-RELATED PROTEIN; CBFA2T3 PROTEIN, HUMAN; DNA BINDING PROTEIN; MESSENGER RNA; MULTIPROTEIN COMPLEX; ONCOPROTEIN; PHOSPHOPROTEIN; PRIMER DNA; RECOMBINANT PROTEIN; REPRESSOR PROTEIN; RUNX1T1 PROTEIN, HUMAN; SIN3B PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ADULT; AMINO TERMINAL SEQUENCE; ANTIBODY SPECIFICITY; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; COS-7 CELL LINE; ECTOPIC EXPRESSION; FETUS; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOLOCALIZATION; IMMUNOPRECIPITATION; K-562 CELL LINE; NHR2 DOMAIN; PLACENTAL CELL LINE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; CELL LINE; CELL STRAIN COS1; CELL STRAIN K 562; CERCOPITHECUS; CHEMISTRY; FEMALE; GENETIC TRANSFECTION; GENETICS; LEUKEMIA; METABOLISM; NUCLEOLUS; NUCLEOTIDE SEQUENCE; PLACENTA; PREGNANCY; PROTEIN TERTIARY STRUCTURE; TISSUE DISTRIBUTION;

ANIMALS; BASE SEQUENCE; CELL LINE; CELL NUCLEOLUS; CERCOPITHECUS AETHIOPS; COS CELLS; DNA PRIMERS; DNA-BINDING PROTEINS; FEMALE; HUMANS; K562 CELLS; LEUKEMIA; MULTIPROTEIN COMPLEXES; PHOSPHOPROTEINS; PLACENTA; PREGNANCY; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS; RECOMBINANT PROTEINS; REPRESSOR PROTEINS; RNA, MESSENGER; TISSUE DISTRIBUTION; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

EID: 41449095241     PISSN: None     EISSN: 14712199     Source Type: Journal    
DOI: 10.1186/1471-2199-9-8     Document Type: Article

References (48)

1. Vettese-Dadey M, Grant PA, Hebbes TR, Crane- Robinson C, Allis CD, Workman JL: Acetylation of histone H4 plays a primary role in enhancing transcription factor binding to nucleosomal DNA in vitro. Embo J 1996, 15(10):2508-2518.
2. Sternberg PW, Stern MJ, Clark I, Herskowitz I: Activation of the yeast HO gene by release from multiple negative controls. Cell 1987, 48(4):567-577.
3. Nasmyth K, Stillman D, Kipling D: Both positive and negative regulators of HO transcription are required for mother-cellspecific mating-type switching in yeast. Cell 1987, 48(4):579-587.
4. Ahringer J: NuRD and SIN3 histone deacetylase complexes in development. Trends Genet 2000, 16(8):351-356.
5. Alland L, Muhle R, Hou H Jr., Potes J, Chin L, Schreiber-Agus N, DePinho RA: Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature 1997, 387(6628):49-55.
6. Heinzel T, Lavinsky RM, Mullen TM, Soderstrom M, Laherty CD, Torchia J, Yang WM, Brard G, Ngo SD, Davie JR, Seto E, Eisenman RN, Rose DW, Glass CK, Rosenfeld MG: A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 1997, 387(6628):43-48.
7. Zhang Y, Iratni R, Erdjument-Bromage H, Tempst P, Reinberg D: Histone deacetylases and SAP18, a novel polypeptide, are components of a human Sin3 complex. Cell 1997, 89(3):357-364.
8. Schreiber-Agus N, Chin L, Chen K, Torres R, Rao G, Guida P, Skoultchi AI, DePinho RA: An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3. Cell 1995, 80(5):777-786.
9. Silverstein RA, Ekwall K: Sin3: A flexible regulator of global gene expression and genome stability. Curr Genet 2005, 47(1):1-17.
10. Ishikawa K, Nagase T, Suyama M, Miyajima N, Tanaka A, Kotani H, Nomura N, Ohara O: Prediction of the coding sequences of unidentified human genes. X. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro. DNA Res 1998, 5(3):169-176.
11. Amann JM, Nip J, Strom DK, Lutterbach B, Harada H, Lenny N, Downing JR, Meyers S, Hiebert SW: ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain. Mol Cell Biol 2001, 21(19):6470-6483.
12. Lutterbach B, Westendorf JJ, Linggi B, Patten A, Moniwa M, Davie JR, Huynh KD, Bardwell VJ, Lavinsky RM, Rosenfeld MG, Glass C, Seto E, Hiebert SW: ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors. Mol Cell Biol 1998, 18(12):7176-7184.
13. Wang J, Hoshino T, Redner RL, Kajigaya S, Liu JM: ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex. Proc Natl Acad Sci U S A 1998, 95(18):10860-10865.
14. Gamou T, Kitamura E, Hosoda F, Shimizu K, Shinohara K, Hayashi Y, Nagase T, Yokoyama Y, Ohki M: The partner gene of AML1 in t(16;21) myeloid malignancies is a novel member of the MTG8(ETO) family. Blood 1998, 91(11):4028-4037.
15. Kitabayashi I, Ida K, Morohoshi F, Yokoyama A, Mitsuhashi N, Shimizu K, Nomura N, Hayashi Y, Ohki M: The AML1-MTG8 leukemic fusion protein forms a complex with a novel member of the MTG8(ETO/CDR) family, MTGR1. Mol Cell Biol 1998, 18(2):846-858.
16. Morohoshi F, Mitani S, Mitsuhashi N, Kitabayashi I, Takahashi E, Suzuki M, Munakata N, Ohki M: Structure and expression pattern of a human MTG8/ETO family gene, MTGR1. Gene 2000, 241(2):287-295.
17. Wolford JK, Prochazka M: Structure and expression of the human MTG8/ETO gene. Gene 1998, 212(1):103-109.
18. Feinstein PG, Kornfeld K, Hogness DS, Mann RS: Identification of homeotic target genes in Drosophila melanogaster including nervy, a proto-oncogene homologue. Genetics 1995, 140(2):573-586.
19. Hildebrand D, Tiefenbach J, Heinzel T, Grez M, Maurer AB: Multiple regions of ETO cooperate in transcriptional repression. J Biol Chem 2001, 276(13):9889-9895.
20. Lutterbach B, Sun D, Schuetz J, Hiebert SW: The MYND motif is required for repression of basal transcription from the multidrug resistance 1 promoter by the t(8;21) fusion protein. Mol Cell Biol 1998, 18(6):3604-3611.
21. Gelmetti V, Zhang J, Fanelli M, Minucci S, Pelicci PG, Lazar MA: Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO. Mol Cell Biol 1998, 18(12):7185-7191.
22. Melnick A, Carlile GW, McConnell MJ, Polinger A, Hiebert SW, Licht JD: AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocytic leukemia zinc finger protein. Blood 2000, 96(12):3939-3947.
23. Erickson P, Gao J, Chang KS, Look T, Whisenant E, Raimondi S, Lasher R, Trujillo J, Rowley J, Drabkin H: Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. Blood 1992, 80(7):1825-1831.
24. Miyoshi H, Shimizu K, Kozu T, Maseki N, Kaneko Y, Ohki M: T(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc Natl Acad Sci U S A 1991, 88(23):10431-10434.
25. Downing JR: The AML1-ETO chimaeric transcription factor in acute myeloid leukaemia: Biology and clinical significance. Br J Haematol 1999, 106(2):296-308.
26. Lindberg SR, Olsson A, Persson AM, Olsson I: Interactions between the leukaemia-associated ETO homologues of nuclear repressor proteins. Eur J Haematol 2003, 71(6):439-447.
27. McGhee L, Bryan J, Elliott L, Grimes HL, Kazanjian A, Davis JN, Meyers S: Gfi-1 attaches to the nuclear matrix, associates with ETO (MTG8) and histone deacetylase proteins, and represses transcription using a TSA-sensitive mechanism. J Cell Biochem 2003, 89(5):1005-1018.
28. McNeil S, Zeng C, Harrington KS, Hiebert S, Lian JB, Stein JL, van Wijnen AJ, Stein GS: The t(8;21) chromosomal translocation in acute myelogenous leukemia modifies intranuclear targeting of the AML1/CBFalpha2 transcription factor. Proc Natl Acad Sci U S A 1999, 96(26):14882-14887.
29. Sacchi N, Tamanini F, Willemsen R, Denis-Donini S, Campiglio S, Hoogeveen AT: Subcellular localization of the oncoprotein MTG8 (CDR/ETO) in neural cells. Oncogene 1998, 16(20):2609-2615.
30. Hoogeveen AT, Rossetti S, Stoyanova V, Schonkeren J, Fenaroli A, Schiaffonati L, van Unen L, Sacchi N: The transcriptional corepressor MTG16a contains a novel nucleolar targeting sequence deranged in t (16; 21)-positive myeloid malignancies. Oncogene 2002, 21(43):6703-6712.
31. Bell P, Dabauvalle MC, Scheer U: In vitro assembly of prenucleolar bodies in Xenopus egg extract. J Cell Biol 1992, 118(6):1297-1304.
32. Gebrane-Younes J, Fomproix N, Hernandez-Verdun D: When rDNA transcription is arrested during mitosis, UBF is still associated with non-condensed rDNA. J Cell Sci 1997, 110 ( Pt 19):2429-2440.
33. Lindberg SR, Olsson A, Persson AM, Olsson I: The Leukemia-associated ETO homologues are differently expressed during hematopoietic differentiation. Exp Hematol 2005, 33(2):189-198.
34. Hassig CA, Fleischer TC, Billin AN, Schreiber SL, Ayer DE: Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell 1997, 89(3):341-347.
35. Amann JM, Chyla BJ, Ellis TC, Martinez A, Moore AC, Franklin JL, McGhee L, Meyers S, Ohm JE, Luce KS, Ouelette AJ, Washington MK, Thompson MA, King D, Gautam S, Coffey RJ, Whitehead RH, Hiebert SW: Mtgr1 is a transcriptional corepressor that is required for maintenance of the secretory cell lineage in the small intestine. Mol Cell Biol 2005, 25(21):9576-9585.
36. Lausen J, Cho S, Liu S, Werner MH: The nuclear receptor corepressor (N-CoR) utilizes repression domains I and III for interaction and co-repression with ETO. J Biol Chem 2004, 279(47):49281-49288.
37. Kozu T, Miyoshi H, Shimizu K, Maseki N, Kaneko Y, Asou H, Kamada N, Ohki M: Junctions of the AML1/MTG8(ETO) fusion are constant in t(8;21) acute myeloid leukemia detected by reverse transcription polymerase chain reaction. Blood 1993, 82(4):1270-1276.
38. Barseguian K, Lutterbach B, Hiebert SW, Nickerson J, Lian JB, Stein JL, van Wijnen AJ, Stein GS: Multiple subnuclear targeting signals of the leukemia-related AML1/ETO and ETO repressor proteins. Proc Natl Acad Sci U S A 2002, 99(24):15434-15439.
39. Nagel S, Hambach L, Krauter J, Venturini L, Heidenreich O, Ganser A, Heil G: Analysis of the nuclear distribution of the translocation t(8;21)-derived fusion protein AML1/ETO by confocal laser scanning microscopy. J Hematother Stem Cell Res 2002, 11(2):401-408.
40. Odaka Y, Mally A, Elliott LT, Meyers S: Nuclear import and subnuclear localization of the proto-oncoprotein ETO (MTG8). Oncogene 2000, 19(32):3584-3597.
41. Akhmanova A, Verkerk T, Langeveld A, Grosveld F, Galjart N: Characterisation of transcriptionally active and inactive chromatin domains in neurons. J Cell Sci 2000, 113 Pt 24:4463-4474.
42. Savino TM, Gebrane-Younes J, De Mey J, Sibarita JB, Hernandez-Verdun D: Nucleolar assembly of the rRNA processing machinery in living cells. J Cell Biol 2001, 153(5):1097-1110.
43. Zhou Y, Santoro R, Grummt I: The chromatin remodeling complex NoRC targets HDAC1 to the ribosomal gene promoter and represses RNA polymerase I transcription. Embo J 2002, 21(17):4632-4640.
44. Pikaard CS: The epigenetics of nucleolar dominance. Trends Genet 2000, 16(11):495-500.
45. Zhai W, Comai L: Repression of RNA polymerase I transcription by the tumor suppressor p53. Mol Cell Biol 2000, 20(16):5930-5938.
46. Heibert SW, Lutterbach B, Durst K, Wang L, Linggi B, Wu S, Wood L, Amann J, King D, Hou Y: Mechanisms of transcriptional repression by the t(8;21)-, t(12;21)-, and inv(16)-encoded fusion proteins. Cancer Chemother Pharmacol 2001, 48 Suppl 1:S31-4.
47. van Ingen H, Baltussen MA, Aelen J, Vuister GW: Role of structural and dynamical plasticity in Sin3: The free PAH2 domain is a folded module in mSin3B. J Mol Biol 2006, 358(2):485-497.
48. Sood R, Zehnder JL, Druzin ML, Brown PO: Gene expression patterns in human placenta. Proc Natl Acad Sci U S A 2006, 103(14):5478-5483.